Loading…
Prostate-specific antigen (PSA) velocity: a test of controversial benefit in the era of increased prostate cancer screening
Determining the need for prostate biopsy remains one of the most controversial questions in urology. Over the past 10 years, practice guidelines have changed dramatically, especially among asymptomatic men with low prostate-specific antigen (PSA) and negative digital rectal exam. Thompson et al.
Saved in:
Published in: | 亚洲男性学杂志:英文版 2011, Vol.13 (4), p.614-615 |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Determining the need for prostate biopsy remains one of the most controversial questions in urology. Over the past 10 years, practice guidelines have changed dramatically, especially among asymptomatic men with low prostate-specific antigen (PSA) and negative digital rectal exam. Thompson et al. |
---|---|
ISSN: | 1008-682X 1745-7262 |